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Abstract
Endoscopic third ventriculostomy (ETV) allows the cerebrospinal fluid (CSF) to flow 
directly from the third ventricle through the fashioned ventriculostoma to the interpe-
duncular cistern, by passing the site of obstruction. In spite of the wide variety of indica-
tions where ETV is implemented, its success rate is still debatable especially in certain 
age groups, where it is most successful in adult patients with obstructive hydrocepha-
lus and it has an identifiable failure rate in children less than 6 months of age. Several 
factors would affect the success rate of ETV, which are related to the patient’s age, 
pathology, and intraoperative findings. This chapter covers most of the current debates 
considering ETV.
Keywords: endoscopic third ventriculostomy, obstructive hydrocephalus, choroid 
plexus coagulation
1. Introduction
In spite of the ongoing advances, endoscopic third ventriculostomy (ETV) remains one of the 
eminent developments in the history of neurosurgery. It allows the cerebrospinal fluid (CSF) 
to flow directly from the third ventricle through the fashioned ventriculostoma to the inter-
peduncular cistern, bypassing the aqueduct and the CSF pathways related to the fourth ven-
tricle and the posterior fossa. The idea of internal visualization of the ventricular system via 
performing surgery through a small hole in the skull was the initiative for the development 
of ETV. During the last decades, ETV ran with the advances in visual and optical technologies 
and made an extraordinary benefit of them.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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The first ever use of an optical tool to visualize the interior of the human body was performed 
by Bozzini in 1806 [1]. A hundred years later, Lespinasse used a cystoscope to visualize the 
ventricles of two hydrocephalic children [2]. In 1918, Dandy performed an endoscopic avul-
sion of the choroid plexus in five hydrocephalic children (where four died) [3]; he called 
his instrument a “ventriculoscope.” In 1922, he opened the floor of the third ventricle by 
sacrificing an optic nerve [3, 4]. In 1923, Mixter performed a third ventriculocisternostomy 
through the anterior fontanelle [5], which is considered the first ever successful ETV. In 1947, 
McNickle was the first to introduce a percutaneous method of performing the third ven-
triculostomy that led to decline of the complication rate, thus improving the success rate [6]. 
Afterward the endoscopic technique progressively developed to reach the current modifica-
tions in the ventriculoscope for better, clear, and safe visualization of the intraventricular 
anatomical structures [7].
There is still a detectable failure rate of all treatment modalities of hydrocephalus. 
However, ETV represents a convenient and easy mode of management. In the recent stud-
ies that evaluated the endoscopic third ventriculostomies performed for the treatment of 
obstructive hydrocephalus, success rates were found between 50 and 94% [8–11]. The type 
of hydrocephalus and age of the patient, in addition to the surgical technique, play an 
important role in the success of the ETV [11]. We will discuss comprehensively the surgical 
technique, indications, and current challenges regarding the increase of the success rate of 
the ETV.
2. Endoscopic anatomy
A preoperative MRI is almost always needed prior to surgery. From the frontal coronal burr 
hole, one reaches first the central part of the lateral ventricle near the frontal horn. The frontal 
horn is demarcated by the absence of choroid plexus. The lateral wall is formed by the nucleus 
with subependymal veins; medially is the septum pellucidum with septal veins. The choroid 
plexus and the foramen of Monro are very important landmarks for the central part of the lat-
eral ventricle. The plexus is situated in the floor of the lateral ventricle, the thalamostriate vein 
lies laterally, and the septal vein’s meeting point is on the medial wall; these three structures 
form the Y-shaped configuration necessary for orientation. The foramen of Monro is formed 
anterolaterally by the fornix, posteromedially by the anterior thalamic tubercle (Figure 1). On 
looking backwards with the endoscope, the body of the lateral ventricle back to the region of 
the trigone, with the body of the caudate laterally underlying the thalamostriate vein and the 
stria terminalis thalami. Adequate orientation of the morbid anatomy that can occur due to 
chronic hydrocephalus is needed [12–14].
By entering the foramen of Monro, the floor of the anterior part of the third ventricle is clearly 
identifiable, with the mammillary bodies and tuber cinereum as the two main structures 
needed for the anatomical orientation (Figure 1) [14].
Liliequist’s membrane is an arachnoid leaflet situated in the basal cisterns and is a very impor-
tant anatomical structure in the postsellar region.
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3. Indications
ETV is considered the first management option in adult patients with obstructive hydrocephalus 
by many neurosurgeons. It is a reliable management option in adults with aqueductal stenosis 
with a success rate that reach 88% [15]. Stenosis at the aqueduct of Sylvius can be congenital or 
acquired. In three quarters of cases, the root cause might be unknown [16]. It is not considered 
as a stable condition as it can be tolerated for years, where stenosis is aggravated by trauma, 
subarachnoid hemorrhage, viral infection, or gradual accumulation of the CSF proximal to the 
aqueduct in partial obstruction [16–18]. In a previous study, clinical improvement with identifi-
able success of the procedure was detected in 86.4% of cases [19], where the success rate was 
lower in secondary ETV after VP shunt (Figure 2). This would be better identified in patients 
with previous history of multiple VP shunt revisions where the ETV failure is relatively more 
encountered [19, 20]. ETV is also preferred as the first-line management of hydrocephalus due 
to obstruction of the aqueduct of Sylvius with pineal tumors or tectal gliomas [21–23].
ETV is less successful in pediatric age groups, with the lowest success rate in children younger 
than 6 months of age, even in aqueductal stenosis [24, 25].
The application of the ETV has been expanded to patients with hydrocephalus associated with 
fourth ventricular outlet obstruction, Dandy-Walker malformation [26], Chiari malformation 
[27–29], communicating hydrocephalus [30], and normal pressure hydrocephalus [31, 32]. 
Figure 1. (A) Endoscopic view of the foramen of Monro (f) and its boundaries. (B) Endoscopic view of the floor of the third 
ventricle before perforation for ETV showing the planned site of perforation (asterisk) in between the tuber cinereum (t) 
and the mammillary bodies (m). (C) Endoscopic visualization of the membrane of Liliequist after perforation (arrow). 
(D) Endoscopic visualization of the basilar artery after opening the membrane of Liliequist (arrowhead).
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However, in exclusion to adult-type obstructive hydrocephalus, there is still a lack of strong 
evidence that supports the procedure.
4. Surgical technique
Under general anesthesia, the patient is restrained, disinfected, and draped as for a frontal 
burr hole; after opening the dura, a small corticectomy is performed, and a blunt obturator 
cannula is inserted, with free hands, directed medially toward the ipsilateral medial epican-
thus and posteriorly toward the tragus of the ear. After insuring being in the ventricles by the 
outflow of CSF, the optical visualization system is inserted; we use the Lotta endoscope (Karl 
Storz, Tuttlingen, Germany) [7].
The first structure identified is the foramen of Monro, with the choroid plexus attached to 
the posterior margin (Figure 1A). The endoscope is introduced through the foramen to the 
third ventricle, and the floor is identified (Figure 1B). A small puncture is done using the decq 
forceps as posterior as possible to the infundibular recess and avoiding the mammillary bod-
ies and the small arterioles running in this area. The endoscope is then advanced near to the 
puncture to visualize Liliequist’s membrane which must be opened, after which, the CSF flow 
should be clearly visualized through the opening (Figure 1C,D).
It is important to clearly visualize the fornix before introducing the endoscope to the third 
ventricle. Opening the floor of the third ventricle with ballooning the fenestra aiming for its 
Figure 2. CT of the brain of a previously shunted 12-year-old male with aqueductal stenosis that had signs of increased 
tension and VP shunt failure; the CT shows enlarged ventricles (A) where ETV was performed without removing the 
shunt. Follow-up CT of the brain 3 months afterward showed decline in the ventricular size (B) which was accompanied 
by clinical improvement of the patient.
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widening, with subsequent opening of the liliquist membrane, is important for a direct visu-
alization of a naked basilar artery (BA) [25]. A delicate surgical technique is required with 
experienced hands during the opening of the floor of the third ventricle till the BA is clearly 
visualized to avoid major vascular injury [33].
5. Outcome
5.1. Clinical evaluation and radiological evaluation
The ETV Success Score (ETVSS) has been developed and validated to predict ETV success 
based on certain variables [34, 35]. It depends on predicting the success according to the 
age of the patient, cause of hydrocephalus, and presence of the previous shunt operation. 
The success rate can be predicted according to these variables. However, intraoperative 
factors “like the presence of excessive adhesions, mobility of the stoma, excessive bleeding, 
and opening of Liliequist’s membrane” (Figure 3) should be taken into consideration in 
predicting the success of ETV [36]. In addition, the VP shunt independence is considered 
a generalized but competent method to measure the success of ETV after VP shunt failure 
[37, 38].
The change of the ventricular size with a deterioration of the clinical condition has been 
well known as one of the signs that identify hydrocephalus. In addition, the decrease of 
the ventricular size after management which accompanied improvement of the general 
condition has its additional value of success confirmation (Figure 2). However, the change 
of the ventricular size is not well supported as an accurate measurement of the effective 
treatment of hydrocephalus, especially when it is irrelevant to the clinical condition of the 
patient [39].
Specific intraoperative factors are considered significant in addition to the associated morbid-
ity. This would include the duration of surgery, type(s) of endoscope used, and degree of 
intraoperative bleeding [33, 36].
Figure 3. Another patient during ETV where thick arachnoid membranes (arrow) surrounding the basilar artery (b) 
denoting possibility of ETV failure.
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6. Challenges and complications
ETV is considered a safe and direct procedure by a huge group of neurosurgeons, and on the 
contrary due to the low incidence of mortality due to vascular injury, a fatal risk in comparison 
to VP shunt implantation is considered by another group of neurosurgeons [33]. Insertion of 
a foreign hardware to the human’s body is always associated with increased risk of infection 
and/or hardware malfunction, which favors the trial of the ETV as a primary management 
modality especially in adult patients with obstructive hydrocephalus [15]. On the contrary, 
late failure or reclosure is considered as a potential risk that can be fatal after ETV [40].
The success of the secondary ETV after ventricular shunt insertion is still debatable, where 
some studies identified the previous shunting procedure as a weakening factor against the 
ETV success [19, 41]. Other studies mentioned the success of the secondary ETV in hinder-
ing the shunt dependency [42, 43]. In our opinion, ETV is considered a competent treatment 
option in cases with obstructive hydrocephalus with repeated VP shunt failure. It can be eas-
ily tried and may lead to shunt independency.
Seven to ten percent of patients with Chiari type I present with hydrocephalus [44–46]. ETV 
has proven to be highly effective in the treatment of obstructive hydrocephalus, thus explain-
ing its increasing use in cases of Chiari I-associated hydrocephalus [27, 47–50] with some 
limitations. The literature shows that most of patients may benefit from ETV. Syringomyelia 
shows better improvement than CIM. This is most probably due to the obvious role of hydro-
cephalus and increased pressure in the development of syrinx.
The large incidence of ETV failure in children leads to increased rate of shunt dependency 
in pediatric age groups, even in obstructive hydrocephalus [24]. The drop of the number of 
children where ETV is successful is thought due to the rapid formation of the arachnoid and 
scar membranes in children which closed the ventriculostoma rapidly [51]. On the contrary 
some authors support the ETV as effective management of obstructive hydrocephalus even in 
young children [52]. Other authors report the clear impact of age on the success rate of ETV 
when talking about infants, where the success rate increases gradually during the first months 
of life. Many studies were performed to determine the cause of failure in young children thus 
poor absorption of CSF and closure of the ventriculostoma or formation of new arachnoid 
membranes in the basal cisterns [51, 53]. In addition, reduced absorption of CSF as a cause of 
failure of ETV was recognized by many authors [54, 55] to be related to poor absorption from 
the arachnoid villi in young children and to the high compliance of the newborn skull in rela-
tion to older children leading to less CSF pressure gradient across the arachnoid villi, added 
to the previously mentioned probable failure due to arachnoid scarring (Figure 3) [56]. This 
was the initiative to relaunch the choroid plexus coagulation (CPC) technique to decrease the 
CSF production: thus, it would increase the success of ETV when performed together.
Due to repeated reports about failure in patients below 2 years old [57–59], a consideration of 
not doing this procedure in this age group has been implemented; however, it is now widely 
accepted that the etiology of the hydrocephalus rather than the age of the patient is more 
important in determining the efficacy of ETV even in patients less than 2 years old [60]. ETV 
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has been shown to be less effective in patients with myelomeningocele and intraventricular 
hemorrhage, while having a similar success rate to adults in cases of aqueductal stenosis [60].
6.1. Choroid plexus coagulation
Choroid plexus coagulation is the surgical ablation of the choroid plexus either endoscopic or 
microscopic [61]. It has recently become popular as a method of management of hydrocepha-
lus not caused by the overproduction of CSF [62–65].
Since 2005, the combination of CPC and ETV became more popular but ever since remained 
a debatable issue [66]. Warf and colleagues published their results of ETV + CPC in 2005; the 
majority of patients were infants. The long-term outcome and neurocognitive results were 
reported in later studies and showed that ETV + CPC increased the success rate from 20 to 
47% to 63 to 76%. In North American experience, multicentric studies proved the safety of 
combined ETV/CPC procedure with technical improvement [67–69].
In 2004, Morota described the technique of CPC through a parietal burr hole using a flexible 
endoscope and monopolar cautery [70]. Warf described the combined ETV/CPC procedure 
using the flexible endoscope, through a frontal burr hole. Bilateral CPC adds 15–30 minutes 
to the procedure; adequate coagulation is realized by the blanching of all visible parts of the 
choroid plexus and the associated blood vessels [61, 66, 67]. The overall mortality (within 
30 days of the surgery) was 1.3%. There was no increase in mortality compared to those with 
ETV alone and those with ETV + CPC [61, 66].
6.2. Communicating hydrocephalus
Patients with postinfectious and posthemorrhagic hydrocephalus have not been included in 
ETV studies in significant numbers. Instead, such patients are considered by many authors to 
be prone to failure of ventriculostomy, thus contraindicating ETV [48, 71, 72].
Posthemorrhagic hydrocephalus of prematurity (PHHP) is one of the most common causes of 
infant hydrocephalus in developed countries; this is mainly due to the high standards of care 
for prematurely born babies [73].
PHHP occurs when blood in the CSF-filled spaces, together with the initial inflammatory 
reaction in the ependyma, would lead to obstruction of CSF outflow and hinder absorption, 
usually by the mechanism of posterior fossa arachnoiditis and aqueductal obstruction. In 
addition, a diffuse inflammatory reaction in the basal cisterns could coexist, which supports 
the theory that predict the ETV failure in these cases [73, 74].
On the contrary, putting these in consideration, with the fact that the use of VP shunts in these 
too young patients carries a high risk of failure, makes trial for an ETV a possible choice for 
treating this group of patients, and decreasing shunt dependency [73].
A large multicentric retrospective study showed that patients with obstructive hydrocepha-
lus and history of hemorrhage or infection may be candidates for ETV. In this group ETV is 
reasonably safe, with a success rate that is comparable to the general series. ETV is highly 
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successful when performed in patients with intraventricular hemorrhage (IVH) and pre-
vious shunting; it is also highly successful in patients with primary aqueductal stenosis, 
while patients with history of both hemorrhage and infection are poor candidates for ETV 
[72, 73].
Some authors recommended the use of temporary CSF diversion, such as Ommaya reservoir 
in the acute stage of IVH, and performed the ETV when evidence of ventricular dilatation 
is obvious [75]. Moreover, in adult patients with IVH, studies showed that endoscopic third 
ventriculostomy may be an option in cases of acute intracranial hemorrhage with intraven-
tricular extension in which there is clearly established CSF outflow obstruction, with special 
concern paid toward the surgeon experience [76].
6.3. Redo success rate
The question of in which cases a reclosure of the ETV opening occurs is still not answered. The 
recent data indicate that failure of ETV may occur immediately after the primary procedure, 
where the main cause is poor indication of remaining membranes or even years after where it 
is due to scarring [77, 78]. A redo ETV is supported before deciding to do other CSF diversion 
procedures whenever a failure was encountered, at which the ETVSS predicts the chance of 
successful redo ETV. Failure of the ETV and thus redo ETV can be also predicted by the pres-
ence of excessive prepontine arachnoid membranes in addition the use of external ventricular 
drain EVD [78, 79].
6.4. Dandy-Walker malformation
In such cases, hydrocephalus is caused by a large posterior fossa cyst in cases of Dandy-
Walker malformation. ETV alone, with aqueductal stent, or with fenestration of the cyst can 
be sufficient in some cases to control hydrocephalus [80, 81].
Cystoventricular stent placement with endoscopic third ventriculostomy is a promising alter-
native in patients with Dandy-Walker malformation with aqueductal obstruction [26].
6.5. Normal pressure hydrocephalus
ETV has been recently introduced as a treatment option for normal pressure hydrocephalus. 
Gangemi et al. mentioned an overall success rate of 72%, in a series of 25 patients [31]. In a 
larger multicentric study, the clinical improvement reached 69.1%, where the improvement 
was correlated to the short clinical history, better neurological score before the operation, 
and the intraoperative appearance of normal cerebral pulsations [82]. Hailong et al. reported 
an 82.35% success rate and claimed that the preoperative Kiefer score and the patient’s age 
are significant prognostic factors for ETV dysfunction [30]. However, the criteria of patients’ 
selection and the small sample size in most previous literature would justify the actual defi-
ciency of solid evidence that supports ETV as a treatment option in normal pressure hydro-
cephalus. Large-scale clinical studies are needed to reach better evidence and define the role 
of ETV in the management of INPH [83].
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7. Complications
In a previous literature review, the overall complication rate was 8.5%; among the individual 
series, the rate ranged from 0 to 31.2%. Complications reported in the immediate postop-
erative period were mainly hemorrhagic, infectious, subdural collections and CSF leak [84]. 
These complications represent actually the same complications that can be encountered with 
the ventricular shunting in exclusion of the hardware-related complications with variable 
incidence rates that can differ according to the variable age groups.
In conclusion, although ETV is considered a reliable resort to control the hydrocephalus with-
out implanting a shunt, the debate on its success rate is still not finalized especially in young 
children and communicating hydrocephalus. So that more studies covering those types are 
warranted.
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